ClinicalTrials.gov
ClinicalTrials.gov Menu

Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery (FCAD02)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00838383
Recruitment Status : Completed
First Posted : February 6, 2009
Last Update Posted : February 7, 2012
Sponsor:
Information provided by (Responsible Party):
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2008
  Actual Study Completion Date : March 2008
  Certification/Extension First Submitted : January 27, 2012